| Date | Title | Description |
| 03.04.2024 | Alterome Therapeutics Raises $132 Million in Series B Financ... | - |
| 26.03.2024 | Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Gr... | - |
| 20.03.2024 | Capstan Therapeutics Announces $175M Oversubscribed Series B... | - |
| 21.02.2024 | ReCode Therapeutics Announces First Participants Dosed in a ... | - |
| 16.02.2024 | Intellia Therapeutics and ReCode Therapeutics Announce Strat... | - |
| 10.02.2024 | Kyverna Therapeutics Announces Pricing of Upsized Initial Pu... | - |
| 30.01.2024 | AVROBIO and Tectonic Therapeutic Announce Merger | - |
| 04.01.2024 | Kyverna’s KYV-101 Receives U.S. FDA Clearance for Treatment ... | - |
| 03.01.2024 | Aktis Oncology to Present at the 42nd Annual J.P. Morgan Hea... | - |
| 03.01.2024 | ReCode Therapeutics Doses First Patient in Phase 1 Clinical ... | - |
| 03.01.2024 | Alterome Named BioSpace’s NextGen Class of 2024: Top Life Sc... | - |
| 13.12.2023 | Kyverna Therapeutics Granted FDA Fast Track Designation for ... | - |
| 28.11.2023 | Tectonic Therapeutic Announces Start of First Clinical Progr... | - |
| 17.11.2023 | Kyverna Therapeutics Announces Publication in The Lancet Neu... | - |
| 13.11.2023 | Affini-T Therapeutics Appoints Healthcare Capital Markets Ve... | - |
| 09.11.2023 | Avalyn Presents Data from its AP01 and AP02 Inhaled Therapeu... | - |
| 31.10.2023 | Affini-T Therapeutics to Present Preclinical Gene Editing Da... | - |
| 30.10.2023 | Volastra Therapeutics Announces First Patient Dosed in Phase... | - |
| 24.10.2023 | Scorpion Therapeutics Appoints Precision Medicine Leader Jef... | - |
| 17.10.2023 | Vigil Neuroscience Announces First Participant Dosed in Phas... | - |
| 13.10.2023 | Scorpion Therapeutics Presents Preclinical Data for STX-241,... | - |
| 11.10.2023 | Quanta Therapeutics Presents Late-Breaking Data for QTX3034,... | - |
| 10.10.2023 | Scorpion Therapeutics and Pierre Fabre Laboratories Announce... | - |
| 27.09.2023 | Avalyn Raises $175 Million in Oversubscribed Series C Financ... | - |
| 03.08.2023 | Kyverna Therapeutics Extends Series B Financing Round to $14... | - |
| 11.07.2023 | IconOVir Bio Announces First Patient Dosed in Phase 1 Clinic... | - |
| 10.07.2023 | Centessa Pharmaceuticals Announces Dosing of First Subject i... | - |
| 29.06.2023 | Kyverna Therapeutics Announces First Patient Enrolled in Pha... | - |
| 22.05.2023 | Centessa Pharmaceuticals Receives Fast Track Designation fro... | - |
| 22.05.2023 | Quanta Therapeutics Raises Over $50 Million in Series D Fina... | - |
| 02.05.2023 | Scorpion Therapeutics Announces First Patient Dosed in Phase... | - |
| 13.04.2023 | Affini-T Therapeutics Announces Licensing Agreement with Lea... | - |
| 03.04.2023 | Scorpion Therapeutics Nominates STX-241 as Potentially Best-... | - |
| 15.03.2023 | Biomarker Interviews 23 Rising Stars in Biotech Investing an... | - |
| 07.03.2023 | Volastra Therapeutics In-Licenses Clinical Stage KIF18A Inhi... | - |
| 24.01.2023 | Fierce Biotech Article – January 23, 2023 | - |
| 05.01.2023 | Affini-T Therapeutics to Present at the 41st Annual J.P. Mor... | - |
| 28.11.2022 | AstraZeneca to acquire Neogene Therapeutics, accelerating am... | - |
| 07.11.2022 | Scorpion Therapeutics Announces Formation of World-Class Cli... | - |
| 02.11.2022 | Alterome Therapeutics Extends Series A to Nearly $100 Millio... | - |
| 22.09.2022 | The Endpoints 11: The top private biotechs in pursuit of new... | - |
| 14.09.2022 | Capstan Therapeutics Launches with $165 Million to Deliver o... | - |
| 12.09.2022 | Scorpion Therapeutics, Volastra Therapeutics and ReCode Ther... | - |
| 26.07.2022 | Affini-T Therapeutics Appoints Pioneering T Cell Therapy and... | - |
| 20.07.2022 | Axel Hoos Wants to Take Small Molecules Further at Scorpion,... | - |
| 12.07.2022 | Affini-T Therapeutics Appoints Jill DeSimone to its Board of... | - |
| 29.06.2022 | ReCode Therapeutics to Expand Next-Generation Delivery Platf... | - |
| 29.06.2022 | Scorpion Therapeutics Nominates STX-721 as EGFR-EXON-20 Deve... | - |
| 15.06.2022 | Affini-T Therapeutics & Metagenomi Announce Next-Generat... | - |
| 02.06.2022 | Scorpion Therapeutics Announces Discovery Scientific Advisor... | - |
| 02.06.2022 | Clinical Strategy for Enhancing Affini-T Therapeutics’ Merke... | - |
| 16.05.2022 | Arie Belldegrun, M.D. Named one of Fierce Pharma’s Most Infl... | - |
| 03.05.2022 | Affini-T Therapeutics’ KRAS TCR T Cell Therapy Program to be... | - |
| 08.04.2022 | Scorpion Therapeutics Presents Preclinical Proof-of-Concept ... | - |
| 05.04.2022 | Affini-T Expands Board of Directors with Appointments of Mic... | - |
| 04.04.2022 | Scorpion Therapeutics Appoints Saurabh Saha, M.D., Ph.D. To ... | - |
| 22.03.2022 | Affini-T Therapeutics Completes $175 Million Financing Co-Le... | - |
| 21.03.2022 | Volastra Therapeutics Announces Drug Discovery Collaboration... | - |
| 01.03.2022 | Helen S. Kim Joins IGI’s HS Chau Women in Enterprising Scien... | - |
| 19.01.2022 | Alterome Therapeutics Launches With $64M Series A Financing | - |
| 13.01.2022 | Scorpion Therapeutics Enters Agreement With Astrazeneca To D... | - |
| 11.01.2022 | Vigil Neuroscience Announces Closing of Initial Public Offer... | - |
| 06.01.2022 | Kyverna Therapeutics Announces Exclusive Worldwide Licenses ... | - |
| 22.11.2021 | Scorpion Therapeutics Announces Appointment of Brian Piper a... | - |
| 17.11.2021 | Protego Biopharma Raises $51 Million Series A Financing to A... | - |
| 26.10.2021 | Quanta Therapeutics Announces Oversubscribed $60 Million Ser... | - |
| 21.10.2021 | ReCode Therapeutics Raises Oversubscribed Series B Financing... | - |
| 20.10.2021 | LianBio Announces Launch of Initial Public Offering | - |
| 09.09.2021 | Centessa Pharmaceuticals Announces Positive Topline Data fro... | - |
| 18.08.2021 | Vigil Neuroscience Completes $90 million Series B Financing ... | - |
| 07.07.2021 | Scorpion Therapeutics Announces New CEO Axel Hoos, M.D., Ph.... | - |
| 24.06.2021 | Vida Ventures Closes $825 Million Vida III Fund to Advance T... | - |
| 21.06.2021 | Centessa Announces Closing of Initial Public Offering and Fu... | - |
| 10.05.2021 | Centessa Pharmaceuticals Appoints One of the World’s Leading... | - |
| 15.04.2021 | Tectonic Therapeutic Launches with $80 Million Series A Fina... | - |
| 18.03.2021 | Aktis Oncology Announces $72M Series A Financing To Advance ... | - |
| 16.02.2021 | Centessa Pharmaceuticals Launches with $250 Million Series A... | - |
| 07.01.2021 | Scorpion Therapeutics Announces Oversubscribed $162 Million ... | - |
| 05.01.2021 | IconOVir Bio Raises $77 Million in Series A Financing to Dev... | - |
| 23.12.2020 | A2 Biotherapeutics Enters Into Collaboration Agreement With ... | - |
| 14.12.2020 | Locanabio Announces $100 Million Series B Financing to Advan... | - |
| 14.12.2020 | InnoSkel Launches with $20 Million Series A Financing | - |
| 07.12.2020 | Kinnate Biopharma Announces Closing of Initial Public Offeri... | - |
| 03.12.2020 | Kinnate Biopharma Announces Pricing of Initial Public Offeri... | - |
| 20.11.2020 | Precision Medicine Group Secures Major Investment from Black... | - |
| 19.11.2020 | Pfizer and LianBio Announce Strategic Collaboration to Expan... | - |
| 18.11.2020 | PIONYR Immunotherapeutics Initiates Phase 1 Clinical Study O... | - |
| 29.10.2020 | LianBio Announces $310 Million Crossover Financing | - |
| 26.10.2020 | Scorpion Therapeutics Launches with $108 Million to Advance ... | - |
| 26.10.2020 | Bayer Acquires Asklepios BioPharmaceutical to Broaden Innova... | - |
| 20.10.2020 | Praxis Precision Medicines Announces Closing of Initial Publ... | - |
| 16.10.2020 | Praxis Precision Medicines Announces Pricing of Upsized Init... | - |
| 14.10.2020 | Kronos Bio Announces Closing of Initial Public Offering and ... | - |
| 09.10.2020 | Kronos Bio Announces Pricing of Initial Public Offering | - |
| 06.10.2020 | Neogene Therapeutics Appoints Former Roche Chairman and Chie... | - |
| 06.10.2020 | A2 Biotherapeutics Closes $71.5M Series B to Begin Clinical ... | - |
| 22.09.2020 | Dyne Therapeutics Announces Closing of Initial Public Offeri... | - |
| 17.09.2020 | Dyne Therapeutics Announces Pricing of Initial Public Offeri... | - |
| 14.09.2020 | Neogene Therapeutics Raises $110 Million Series A Financing ... | - |
| 26.08.2020 | Kinnate Biopharma Closes $98 Million Series C Financing | - |
